Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. Sandoz completed its long-heralded separation from Novartis on schedule this morning, with its shares trading at CHF 24 on the SIX Swiss Exchange. Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Sandoz Inc. manufactures, markets and/or distributes more than 174 drugs in the United States. Medications listed here may also be marketed under different names in different countries. About Sandoz About Us Therapeutic Areas Biosimilars Products Patients and Customers News Contact Us Contact Us Patient Support Medical Inquiry Adverse Events Careers My Orders Information for Customers My Orders Order Support Return Policy CPSIA Certification Terms of Use Privacy Policy About Cookies Legal Notice The Sandoz brand is a seal of quality, and healthcare professionals around the world trust it as a symbol of high-quality, affordable medications. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886.